ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - CELLDEX THERAPEUTICS INC ownership

CELLDEX THERAPEUTICS INC's ticker is and the CUSIP is 15117B10. A total of 4 filers reported holding CELLDEX THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of CELLDEX THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$1,111,000
-47.3%
274,941
+130.3%
0.00%
-69.2%
Q1 2014$2,109,000
-81.7%
119,364
-75.0%
0.01%
-79.4%
Q4 2013$11,543,000476,7700.06%
Other shareholders
CELLDEX THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
NJ State Employees Deferred Compensation Plan 100,000$2,421,0000.49%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 476,770$11,543,0000.06%
State of New Jersey Common Pension Fund A 410,000$9,926,0000.05%
NORTHERN TRUST CO OF CONNECTICUT 880$21,0000.00%
View complete list of CELLDEX THERAPEUTICS INC shareholders